Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia

NCT: NCT05985993 · COMPLETED

NCT IDNCT05985993
StatusCOMPLETED
Start Date2025-04-01
Completion2026-05-31
SponsorShanghai Mental Health Center (OTHER)
First posted
Last updated

Brief Summary

Based on the current background and our previous studies, TUS has been proved that rTUS intervention could induce long-term potentiation like (LTP-like) plasticity and neuromodulate the brain cortex in schizophrenia patients. rTUS over the left dorsolateral prefrontal cortex (DLPFC) can alleviate the negative symptoms in schizophrenia. In this double-blind, randomized, sham-controlled study, the efficacy of different treatment options and mechanisms of low-intensity rTUS on negative symptoms will be investigated.

Frequently Asked Questions

What is Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia?

Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia is a clinical trial registered under NCT05985993. Current status: COMPLETED.

What is the status of NCT05985993?

The current status of NCT05985993 (Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia) is: COMPLETED.

When did Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia start?

Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia started on 2025-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑